Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

NEO – Neogenomics Inc.

NeoGenomics, Inc.
NEO
$5.16
Name : NeoGenomics, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $666,563,648.00
EPSttm : -0.82
finviz dynamic chart for NEO
NeoGenomics, Inc.
$5.16
6.61%
$0.32

Float Short %

3.35

Margin Of Safety %

Put/Call OI Ratio

0.26

EPS Next Q Diff

0.11

EPS Last/This Y

0.73

EPS This/Next Y

0.11

Price

5.16

Target Price

8.14

Analyst Recom

2.33

Performance Q

-28.93

Relative Volume

2.01

Beta

1.54

Ticker: NEO




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04NEO7.550.220.0020976
2025-07-07NEO7.310.220.0321033
2025-07-08NEO7.450.220.0021045
2025-07-09NEO7.530.220.0021047
2025-07-10NEO7.490.220.0121142
2025-07-11NEO7.260.220.1321261
2025-07-14NEO7.180.230.0021198
2025-07-15NEO6.90.220.0621564
2025-07-16NEO6.910.220.0221665
2025-07-17NEO6.710.220.0321671
2025-07-18NEO6.250.220.0721848
2025-07-21NEO6.20.232.3518662
2025-07-22NEO6.420.280.0819427
2025-07-23NEO6.610.280.0019543
2025-07-24NEO6.410.280.1519551
2025-07-25NEO6.290.280.0719567
2025-07-28NEO6.470.280.1519633
2025-07-29NEO5.260.270.5820602
2025-07-30NEO5.090.280.0425573
2025-07-31NEO4.840.260.1225695
2025-08-01NEO5.170.260.9425902
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04NEO7.55-15.4- 0.16
2025-07-07NEO7.31-15.4- 0.16
2025-07-08NEO7.45-15.4- 0.16
2025-07-09NEO7.53-15.4- 0.16
2025-07-10NEO7.49-15.4- 0.16
2025-07-11NEO7.26-15.4- 0.16
2025-07-14NEO7.18-15.4- 0.16
2025-07-15NEO6.90-15.4- 0.16
2025-07-16NEO6.91-15.4- 0.16
2025-07-17NEO6.72-15.4- 0.16
2025-07-18NEO6.24-15.4- 0.16
2025-07-21NEO6.21-15.4- 0.16
2025-07-22NEO6.43-15.4- 0.16
2025-07-23NEO6.61-15.4- 0.16
2025-07-24NEO6.42-15.4- 0.16
2025-07-25NEO6.29-15.4- 0.16
2025-07-28NEO6.47-17.9- 0.16
2025-07-29NEO5.25-17.9- 0.16
2025-07-30NEO5.10-17.9- 0.16
2025-07-31NEO4.84-17.9- 0.16
2025-08-01NEO5.16-43.1- 0.11
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04NEO4.422.643.40
2025-07-07NEO4.422.673.40
2025-07-08NEO4.422.673.40
2025-07-09NEO4.422.673.40
2025-07-10NEO4.422.673.40
2025-07-11NEO4.422.673.58
2025-07-14NEO4.422.763.58
2025-07-15NEO4.422.763.58
2025-07-16NEO4.422.763.58
2025-07-17NEO4.422.763.58
2025-07-18NEO4.422.763.58
2025-07-21NEO4.422.783.58
2025-07-22NEO4.422.783.58
2025-07-23NEO4.422.783.58
2025-07-24NEO4.422.783.58
2025-07-25NEO4.422.783.37
2025-07-28NEO4.42-4.133.37
2025-07-29NEO4.42-4.133.37
2025-07-30NEO4.42-4.133.37
2025-07-31NEO4.42-4.133.37
2025-08-01NEO4.40-4.133.35
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.06

Avg. EPS Est. Current Quarter

0.03

Avg. EPS Est. Next Quarter

0.05

Insider Transactions

4.4

Institutional Transactions

-4.13

Beta

1.54

Average Sales Estimate Current Quarter

185

Average Sales Estimate Next Quarter

191

Fair Value

Quality Score

42

Growth Score

45

Sentiment Score

21

Actual DrawDown %

91.6

Max Drawdown 5-Year %

-91.9

Target Price

8.14

P/E

Forward P/E

26.42

PEG

P/S

0.97

P/B

0.78

P/Free Cash Flow

EPS

-0.82

Average EPS Est. Cur. Y​

0.11

EPS Next Y. (Est.)

0.22

Target Price Estimates Raised

Target Price Estimates Lowered

4

Profit Margin

-15.1

Relative Volume

2.01

Return on Equity vs Sector %

-35.9

Return on Equity vs Industry %

-22.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.05

EBIT Estimation

NeoGenomics, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 2200
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
stock quote shares NEO – Neogenomics Inc. Stock Price stock today
news today NEO – Neogenomics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NEO – Neogenomics Inc. yahoo finance google finance
stock history NEO – Neogenomics Inc. invest stock market
stock prices NEO premarket after hours
ticker NEO fair value insiders trading

NEO – NeoGenomics, Inc.

Name : NeoGenomics, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $0.0000
EPSttm :
finviz dynamic chart for NEO
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=NEO #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=NEO &conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]

Float Short %

3.35

Margin Of Safety %

Put/Call OI Ratio

0.26

EPS Next Q Diff

0.11

EPS Last/This Y

0.73

EPS This/Next Y

0.11

Price

5.16

Target Price

8.14

Analyst Recom

2.33

Performance Q

-28.93

Relative Volume

2.01

Beta

1.54

Ticker: NEO




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04NEO7.550.220.0020976
2025-07-07NEO7.310.220.0321033
2025-07-08NEO7.450.220.0021045
2025-07-09NEO7.530.220.0021047
2025-07-10NEO7.490.220.0121142
2025-07-11NEO7.260.220.1321261
2025-07-14NEO7.180.230.0021198
2025-07-15NEO6.90.220.0621564
2025-07-16NEO6.910.220.0221665
2025-07-17NEO6.710.220.0321671
2025-07-18NEO6.250.220.0721848
2025-07-21NEO6.20.232.3518662
2025-07-22NEO6.420.280.0819427
2025-07-23NEO6.610.280.0019543
2025-07-24NEO6.410.280.1519551
2025-07-25NEO6.290.280.0719567
2025-07-28NEO6.470.280.1519633
2025-07-29NEO5.260.270.5820602
2025-07-30NEO5.090.280.0425573
2025-07-31NEO4.840.260.1225695
2025-08-01NEO5.170.260.9425902
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04NEO7.55-15.4- 0.16
2025-07-07NEO7.31-15.4- 0.16
2025-07-08NEO7.45-15.4- 0.16
2025-07-09NEO7.53-15.4- 0.16
2025-07-10NEO7.49-15.4- 0.16
2025-07-11NEO7.26-15.4- 0.16
2025-07-14NEO7.18-15.4- 0.16
2025-07-15NEO6.90-15.4- 0.16
2025-07-16NEO6.91-15.4- 0.16
2025-07-17NEO6.72-15.4- 0.16
2025-07-18NEO6.24-15.4- 0.16
2025-07-21NEO6.21-15.4- 0.16
2025-07-22NEO6.43-15.4- 0.16
2025-07-23NEO6.61-15.4- 0.16
2025-07-24NEO6.42-15.4- 0.16
2025-07-25NEO6.29-15.4- 0.16
2025-07-28NEO6.47-17.9- 0.16
2025-07-29NEO5.25-17.9- 0.16
2025-07-30NEO5.10-17.9- 0.16
2025-07-31NEO4.84-17.9- 0.16
2025-08-01NEO5.16-43.1- 0.11
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04NEO4.422.643.40
2025-07-07NEO4.422.673.40
2025-07-08NEO4.422.673.40
2025-07-09NEO4.422.673.40
2025-07-10NEO4.422.673.40
2025-07-11NEO4.422.673.58
2025-07-14NEO4.422.763.58
2025-07-15NEO4.422.763.58
2025-07-16NEO4.422.763.58
2025-07-17NEO4.422.763.58
2025-07-18NEO4.422.763.58
2025-07-21NEO4.422.783.58
2025-07-22NEO4.422.783.58
2025-07-23NEO4.422.783.58
2025-07-24NEO4.422.783.58
2025-07-25NEO4.422.783.37
2025-07-28NEO4.42-4.133.37
2025-07-29NEO4.42-4.133.37
2025-07-30NEO4.42-4.133.37
2025-07-31NEO4.42-4.133.37
2025-08-01NEO4.40-4.133.35
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=NEO 589 360 ]

Last Quarter Act. EPS

-0.06

Avg. EPS Est. Current Quarter

0.03

Avg. EPS Est. Next Quarter

0.05

Insider Transactions

4.4

Institutional Transactions

-4.13

Beta

1.54

Average Sales Estimate Current Quarter

185

Average Sales Estimate Next Quarter

191

Fair Value

Quality Score

42

Growth Score

45

Sentiment Score

21

Actual DrawDown %

91.6

Max Drawdown 5-Year %

-91.9

Target Price

8.14

P/E

Forward P/E

26.42

PEG

P/S

0.97

P/B

0.78

P/Free Cash Flow

EPS

-0.82

Average EPS Est. Cur. Y​

0.11

EPS Next Y. (Est.)

0.22

Target Price Estimates Raised

Target Price Estimates Lowered

4

Profit Margin

-15.1

Relative Volume

2.01

Return on Equity vs Sector %

-35.9

Return on Equity vs Industry %

-22.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.05

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=NEO 589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=NEO 589 450 ]
NeoGenomics, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 2200
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
stock quote shares NEO – NeoGenomics, Inc. Stock Price stock today
news today NEO – NeoGenomics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NEO – NeoGenomics, Inc. yahoo finance google finance
stock history NEO – NeoGenomics, Inc. invest stock market
stock prices NEO premarket after hours
ticker NEO fair value insiders trading